Sleep Number Corp stock (US8332141079): Adjustable bed market leader for US investors

Sleep Number Corp, known for its innovative adjustable beds, continues to serve the growing US sleep health market. Recent financials show steady demand amid economic shifts, with shares listed on Nasdaq.

Sleep Number Corp maintains its position in the competitive sleep products industry, focusing on smart adjustable beds that cater to personalized comfort needs. The company reported net sales of $392.5 million for Q4 2025, down 11% year-over-year but with improved gross margin to 65.1%, according to company IR as of Feb 26, 2026. This reflects resilience in a challenging retail environment.

As of: 14.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Sleep Number Corp
• Sector/industry: Consumer discretionary / Sleep products
• Headquarters/country: United States
• Core markets: United States
• Key revenue drivers: Adjustable beds, bedding accessories
• Home exchange/listing venue: Nasdaq (SNBR)
• Trading currency: USD

Sleep Number Corp: core business model

Sleep Number Corp designs, manufactures, and sells adjustable firmness beds and sleep wellness products primarily through its omnichannel retail strategy in the US. The company's Sleep Number® beds feature proprietary SleepIQ® technology that tracks sleep data to optimize comfort. This data-driven approach differentiates it from traditional mattress makers, appealing to health-conscious consumers. For full-year 2025, Sleep Number generated $1.59 billion in revenue, per its annual report published Feb 26, 2026 on IR site as of Feb 26, 2026.

The business model emphasizes direct-to-consumer sales via over 650 stores and online platforms, supplemented by wholesale partnerships. This setup allows for higher margins through brand control and customer data insights, which inform product innovation like the Climate360 smart bed launched in recent years.

Main revenue and product drivers for Sleep Number Corp

Adjustable beds account for over 90% of Sleep Number Corp's revenue, with accessories and bedding contributing the balance. Demand is driven by rising awareness of sleep's role in health, particularly post-pandemic. In Q4 2025, comparable sales declined 13%, yet the company expanded its store base, adding 11 net new locations, as noted in its earnings release. Fleetsize, a key metric for bed units sold, stood at 46,121 for the year.

Product innovation remains central, with smart bed features integrating biometric sensors for sleep tracking. These appeal to US consumers seeking tech-integrated home wellness solutions, aligning with broader trends in the $15 billion US mattress market per Statista data as of 2025.

Industry trends and competitive position

The US sleep industry grows at 5-7% annually, fueled by e-commerce and wellness trends, according to S&P Global as of 2025. Sleep Number Corp holds a niche in premium adjustable beds, competing with Tempur Sealy and Beautyrest. Its SleepIQ platform provides a moat through 10+ years of sleep data from millions of nights tracked.

Challenges include macroeconomic pressures like inflation affecting big-ticket purchases. Yet, Sleep Number's focus on performance bedding has supported margin expansion to 65.1% in Q4 2025 from 62.6% prior year.

Why Sleep Number Corp matters for US investors

Sleep Number Corp offers US investors exposure to the resilient consumer discretionary sector, with 100% revenue from the domestic market. Listed on Nasdaq under SNBR, it benefits from strong brand recognition in sleep health, a category less cyclical than apparel or autos. Shares traded around $11-15 range in early 2026, per Nasdaq data.

Conclusion

Sleep Number Corp navigates a tough retail landscape with innovation in smart sleep tech and disciplined cost management. Full-year 2025 results highlight margin gains despite sales pressure, positioning it for potential recovery in consumer spending. Investors track upcoming quarters for fleetsize trends and bedding growth amid US economic shifts.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.